32 | METABOLIC‐ONLY RESPONSE ASSESSMENT ALLOWS RADIATION OMISSION FOR MAJORITY WITH CLASSICAL HODGKIN LYMPHOMA AND MAINTAINS EXCELLENT OUTCOMES: A PHC PHASE 2 STUDY cHOD17Jamie E. Flerlage, Matthias J. Ehrhardt, Angela M. Feraco et al.|Hematological Oncology|2025Cited by 0
Metabolic-Only Criteria in Pediatric High-Risk (HR) cHL: A Review of Reduced Radiotherapy (RT) Exposure in HLHR13 and cHOD17 TrialsJohn T. Lucas, Matthew J. Ehrhardt, Yinmei Zhou et al.|Klinische Pädiatrie|2025Cited by 0